Selection of a Novel CD19 Aptamer for Targeted Delivery of Doxorubicin to Lymphoma Cells

Oncotarget - United States
doi 10.18632/oncotarget.24902
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Aptamer–drug Conjugate: Targeted Delivery of Doxorubicin in a HER3 Aptamer-Functionalized Liposomal Delivery System Reduces Cardiotoxicity

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Aptamer-Based Targeted Delivery of a G-Quadruplex Ligand in Cervical Cancer Cells

Scientific Reports
Multidisciplinary
2019English

Targeted Delivery of Doxorubicin to HER2 Positive Tumor Models

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2019English

CD19-Targeted T Cells for Hematologic Malignancies

Cancer Journal
Cancer ResearchOncology
2015English

Doxorubicin-Loaded CuS Nanoparticles Conjugated With GFLG: A Novel Drug Delivery System for Lymphoma Treatment

Nano
Materials ScienceNanotechnologyCondensed Matter PhysicsNanoscience
2019English

Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells

English

Redox-Sensitive Gelatin/Silica-Aptamer Nanogels for Targeted siRNA Delivery

Nanoscale Research Letters
Materials ScienceNanotechnologyCondensed Matter PhysicsNanoscience
2019English

AS1411 Aptamer Conjugated Gelatin-Siloxane Nanoparticles for Targeted siRNA Delivery

2017English

Targeted Delivery of Doxorubicin by CSA-binding Nanoparticles for Choriocarcinoma Treatment

Drug Delivery
MedicinePharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy